Search research articles
Contact Us
Filters
Showing results (91-100 of 134) with videos related to
Page
of 14
Sort By:
Frontiers in Pediatrics
|
February 22, 2021
Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus
Constance Carels, Lucas Wauters, An Outtier, et al.
Journal of Crohn'S & Colitis
|
April 17, 2019
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study
Claire Liefferinckx, Bram Verstockt, Ann Gils, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial
David Laharie, Geert D'Haens, Maria Nachury, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 5, 2025
Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment
Remo Panaccione, Marc Ferrante, Iris Dotan, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
February 3, 2016
Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up
Elisabeth De Greef, Ilse Hoffman, Francoise Smets, et al.
Gastroenterology
|
August 8, 2022
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial
Marie Truyens, Triana Lobatón, Marc Ferrante, et al.
Nature Reviews. Gastroenterology & Hepatology
|
August 28, 2021
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
Pablo A Olivera, Stephane Zuily, Paulo G Kotze, et al.
Journal of Crohn'S & Colitis
|
March 6, 2015
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents
Konstantinos Karmiris, Peter Bossuyt, Dario Sorrentino, et al.
Alimentary Pharmacology & Therapeutics
|
April 16, 2019
Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease
Gregor Novak, Toer Stevens, Tanja Van Viegen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 28, 2019
Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease
Eelco C Brand, Sjoerd G Elias, Itta M Minderhoud, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 134) with videos related to
Sort By:
Page
of 14
Frontiers in Pediatrics
|
February 22, 2021
Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus
Constance Carels, Lucas Wauters, An Outtier, et al.
Journal of Crohn'S & Colitis
|
April 17, 2019
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study
Claire Liefferinckx, Bram Verstockt, Ann Gils, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial
David Laharie, Geert D'Haens, Maria Nachury, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 5, 2025
Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment
Remo Panaccione, Marc Ferrante, Iris Dotan, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
February 3, 2016
Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up
Elisabeth De Greef, Ilse Hoffman, Francoise Smets, et al.
Gastroenterology
|
August 8, 2022
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial
Marie Truyens, Triana Lobatón, Marc Ferrante, et al.
Nature Reviews. Gastroenterology & Hepatology
|
August 28, 2021
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
Pablo A Olivera, Stephane Zuily, Paulo G Kotze, et al.
Journal of Crohn'S & Colitis
|
March 6, 2015
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents
Konstantinos Karmiris, Peter Bossuyt, Dario Sorrentino, et al.
Alimentary Pharmacology & Therapeutics
|
April 16, 2019
Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease
Gregor Novak, Toer Stevens, Tanja Van Viegen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 28, 2019
Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease
Eelco C Brand, Sjoerd G Elias, Itta M Minderhoud, et al.
Page
of 14